Literature DB >> 23636856

New obesity indices and adipokines in normotensive patients and patients with hypertension: comparative pilot analysis.

Mariusz Stepien1, Anna Stepien, Maciej Banach, Rafal N Wlazel, Marek Paradowski, Manfredi Rizzo, Peter P Toth, Jacek Rysz.   

Abstract

We compared the obesity parameters and selected adipokines-leptin, adiponectin, and resistin-in obese patients with hypertension and normotensive patients. A total of 67 nondiabetic obese outpatients were divided into 2 groups: A-hypertensive and B-normotensive. Serum levels of leptin, adiponectin, resistin, and insulin were measured. Weight, height, waist circumference, and hip circumference were measured to calculate waist-to-hip ratio (WHR), weight-to-height ratio, visceral adiposity index, and body adiposity index (BAI). Among patients with hypertension, significant positive correlations were observed between leptin and body mass index and BAI (r = .31 and r = .63, respectively). In normotensive patients, leptin positively correlated with BAI (r = .73, P < .01) and negatively with WHR (r = -.55, P < .0001); adiponectin negatively correlated with WHR (r = .38, P < .01) and BAI (r = .52; P < .0001), and resistin negatively correlated with WHR (r = -.36, P < .05). In conclusion, visceral obesity and leptin are associated with hypertension in obese patients.

Entities:  

Keywords:  adipokines; hypertension; obesity; obesity indices

Mesh:

Substances:

Year:  2013        PMID: 23636856     DOI: 10.1177/0003319713485807

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  22 in total

Review 1.  Leptin, cardiovascular diseases and type 2 diabetes mellitus.

Authors:  Niki Katsiki; Dimitri P Mikhailidis; Maciej Banach
Journal:  Acta Pharmacol Sin       Date:  2018-06-07       Impact factor: 6.150

2.  Association between inflammatory biomarkers and thin-cap fibroatheroma detected by optical coherence tomography in patients with coronary heart disease.

Authors:  Kohei Koyama; Kihei Yoneyama; Takanobu Mitarai; Yuki Ishibashi; Eiji Takahashi; Ken Kongoji; Tomoo Harada; Yoshihiro J Akashi
Journal:  Arch Med Sci       Date:  2015-06-19       Impact factor: 3.318

3.  Obesity indices and inflammatory markers in obese non-diabetic normo- and hypertensive patients: a comparative pilot study.

Authors:  Mariusz Stępień; Anna Stępień; Rafał N Wlazeł; Marek Paradowski; Maciej Banach; Jacek Rysz
Journal:  Lipids Health Dis       Date:  2014-02-08       Impact factor: 3.876

4.  Significantly increased visceral adiposity index in prehypertension.

Authors:  Yanan Ding; Dongfeng Gu; Yanxuan Zhang; Wenjie Han; Hengliang Liu; Qingshan Qu
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

5.  Assessment of the relationship between lipid parameters and obesity indices in non-diabetic obese patients: a preliminary report.

Authors:  Anna Stępień; Mariusz Stępień; Rafał N Wlazeł; Marek Paradowski; Maciej Banach; Jacek Rysz
Journal:  Med Sci Monit       Date:  2014-12-16

6.  Circulating Galectin-3 Is Associated With Cardiometabolic Disease in the Community.

Authors:  Matthew Nayor; Na Wang; Martin G Larson; Ramachandran S Vasan; Daniel Levy; Jennifer E Ho
Journal:  J Am Heart Assoc       Date:  2015-12-31       Impact factor: 5.501

7.  Prevalence of overweight, obesity, abdominal obesity and obesity-related risk factors in southern China.

Authors:  Lihua Hu; Xiao Huang; Chunjiao You; Juxiang Li; Kui Hong; Ping Li; Yanqing Wu; Qinhua Wu; Zengwu Wang; Runlin Gao; Huihui Bao; Xiaoshu Cheng
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

Review 8.  Association between serum resistin concentration and hypertension: A systematic review and meta-analysis.

Authors:  Yuxiang Zhang; Yixing Li; Lin Yu; Lei Zhou
Journal:  Oncotarget       Date:  2017-06-20

9.  Visceral adiposity index is strongly associated with hyperuricemia independently of metabolic health and obesity phenotypes.

Authors:  Huimin Dong; Yang Xu; Xiuzhi Zhang; Simiao Tian
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

Review 10.  Visceral adiposity index: an indicator of adipose tissue dysfunction.

Authors:  Marco Calogero Amato; Carla Giordano
Journal:  Int J Endocrinol       Date:  2014-04-14       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.